|601 Congress Street , Boston, MA 02210-2805|
|Fund Manager||Team Managed|
John Hancock Short Duration Credit Opportunities Fund seeks total return by investing in bonds and related investments and maintain an average portfolio duration of 3 years or less. The Fund's benchmark is Bloomberg Barclays 1-5 Year U.S. Credit Index.
|Asset Type||% Of Allocation|
|Total Net Assets||55.30 M|
|Criteria||3 Years||5 Years||10 Years|
|Minimum Initial IRA||$0|
|Timeframe||Average Annual Current Performance Monthly As Of 08/31/2021||Average Annual Current Performance Quarterly As Of 05/31/2021||Avg Annual Current Performance Monthly As Of 08/31/2021||Avg Annual Current Performance Quarterly As Of 05/31/2021|
|Life Of Fund||
Join the Action Alerts PLUS Community today!
Wolfe Research upgraded Chewy to outperform, saying a drop in net new customer additions should reverse in fiscal 2022.
Ahead of third-quarter earnings season, James 'Rev Shark' Deporre has some thoughts on what investors should be thinking about.
Gogo, Huntsman, Thor Industries, United Natural Foods and Sonoma Pharmaceuticals are five top stock gainers for Tuesday.
Stocks are lower as Wall Street contends with rolling blackouts in China, record high energy prices in Europe and gas line-ups in Britain.
Aurora Cannabis had a tough quarter, but Cowen analysts still expect strong growth margins in 2022.
'Redwire offers a diversified portfolio of space components that are well-positioned to capture emerging trends,' Jefferies says.
Uncertain fiscal and monetary policies could prompt a stock correction, the noted bull Phil Orlando says.
Sanofi says its COVID vaccine candidate has positive test results, but the company is ready to drop its development because of the Moderna and Pfizer vaccines.